Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1997 Apr;166(4):253–262.

Management of acute ischemic stroke. An update for primary care physicians.

G W Albers 1
PMCID: PMC1304205  PMID: 9168683

Abstract

Few areas of medicine have had as many major advances in recent years as the treatment and prevention of ischemic stroke. During the 1990s-"the decade of the brain"-carotid endarterectomy was demonstrated to be effective for preventing stroke in patients with significant carotid stenosis. Large clinical studies have documented the effectiveness of new antiplatelet agents and oral anticoagulant therapy for stroke prevention in specific patients groups, and recently tissue plasminogen activator was approved for the treatment of acute ischemic stroke. Because the use of these new therapies is restricted to specific patient subgroups, the accurate determination of the cause of stroke is now mandatory. Fortunately, advances in diagnostic methods, including cardiac and vascular ultrasonographic techniques and brain imaging, facilitate the determination of the stroke subtype in most patients. Additional advances in stroke treatment and prevention are on the immediate horizon. New therapeutic agents, including neuroprotective medications, and new treatment modalities such as cerebral angioplasty are promising investigational therapies.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams H. P., Jr, Brott T. G., Crowell R. M., Furlan A. J., Gomez C. R., Grotta J., Helgason C. M., Marler J. R., Woolson R. F., Zivin J. A. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994 Sep;25(9):1901–1914. doi: 10.1161/01.str.25.9.1901. [DOI] [PubMed] [Google Scholar]
  2. Adams H. P., Jr, Brott T. G., Furlan A. J., Gomez C. R., Grotta J., Helgason C. M., Kwiatkowski T., Lyden P. D., Marler J. R., Torner J. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996 Sep;27(9):1711–1718. [PubMed] [Google Scholar]
  3. Albers G. W., Goldberg M. P., Choi D. W. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol. 1989 Apr;25(4):398–403. doi: 10.1002/ana.410250412. [DOI] [PubMed] [Google Scholar]
  4. Albers G. W., Yim J. M., Belew K. M., Bittar N., Hattemer C. R., Phillips B. G., Kemp S., Hall E. A., Morton D. J., Vlasses P. H. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med. 1996 Nov 11;156(20):2311–2316. [PubMed] [Google Scholar]
  5. Choi D. W. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev. 1990 Summer;2(2):105–147. [PubMed] [Google Scholar]
  6. Clark W. M., Barnwell S. L., Nesbit G., O'Neill O. R., Wynn M. L., Coull B. M. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke. 1995 Jul;26(7):1200–1204. doi: 10.1161/01.str.26.7.1200. [DOI] [PubMed] [Google Scholar]
  7. DeRook F. A., Comess K. A., Albers G. W., Popp R. L. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med. 1992 Dec 1;117(11):922–932. doi: 10.7326/0003-4819-117-11-922. [DOI] [PubMed] [Google Scholar]
  8. Dobkin B. The economic impact of stroke. Neurology. 1995 Feb;45(2 Suppl 1):S6–S9. [PubMed] [Google Scholar]
  9. Donnan G. A., Davis S. M., Chambers B. R., Gates P. C., Hankey G. J., McNeil J. J., Rosen D., Stewart-Wynne E. G., Tuck R. R. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA. 1996 Sep 25;276(12):961–966. [PubMed] [Google Scholar]
  10. Duke R. J., Bloch R. F., Turpie A. G., Trebilcock R., Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med. 1986 Dec;105(6):825–828. doi: 10.7326/0003-4819-105-6-825. [DOI] [PubMed] [Google Scholar]
  11. Enserink M. Fraud and ethics charges hit stroke drug trial. Science. 1996 Dec 20;274(5295):2004–2005. doi: 10.1126/science.274.5295.2004. [DOI] [PubMed] [Google Scholar]
  12. Gage B. F., Cardinalli A. B., Albers G. W., Owens D. K. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995 Dec 20;274(23):1839–1845. [PubMed] [Google Scholar]
  13. Hart R. G., Easton J. D. Hemorrhagic infarcts. Stroke. 1986 Jul-Aug;17(4):586–589. doi: 10.1161/01.str.17.4.586. [DOI] [PubMed] [Google Scholar]
  14. Hass W. K., Easton J. D., Adams H. P., Jr, Pryse-Phillips W., Molony B. A., Anderson S., Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989 Aug 24;321(8):501–507. doi: 10.1056/NEJM198908243210804. [DOI] [PubMed] [Google Scholar]
  15. Kay R., Wong K. S., Yu Y. L., Chan Y. W., Tsoi T. H., Ahuja A. T., Chan F. L., Fong K. Y., Law C. B., Wong A. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1588–1593. doi: 10.1056/NEJM199512143332402. [DOI] [PubMed] [Google Scholar]
  16. Mayberg M. R., Wilson S. E., Yatsu F., Weiss D. G., Messina L., Hershey L. A., Colling C., Eskridge J., Deykin D., Winn H. R. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991 Dec 18;266(23):3289–3294. [PubMed] [Google Scholar]
  17. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol. 1986 Feb;19(2):105–111. doi: 10.1002/ana.410190202. [DOI] [PubMed] [Google Scholar]
  18. Sacco R. L. Risk factors and outcomes for ischemic stroke. Neurology. 1995 Feb;45(2 Suppl 1):S10–S14. [PubMed] [Google Scholar]
  19. Sherman D. G., Dyken M. L., Jr, Gent M., Harrison J. G., Hart R. G., Mohr J. P. Antithrombotic therapy for cerebrovascular disorders. An update. Chest. 1995 Oct;108(4 Suppl):444S–456S. doi: 10.1378/chest.108.4_supplement.444s. [DOI] [PubMed] [Google Scholar]
  20. Siesjö B. K., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab. 1989 Apr;9(2):127–140. doi: 10.1038/jcbfm.1989.20. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES